PDCD1 and neoplasm: In melanoma, the binding of PD-1 onto tumor cells with PD-L1 expressed by the surrounding tumor or stromal cells can activate the mTOR signaling pathway, thereby directly promoting tumor growth independently of immune cell interactions [101].